FDA Inspection 1021133 — Zhejiang Medicine Co. Ltd. Xinchang Pharmaceutical Factory
The FDA completed an inspection of Zhejiang Medicine Co. Ltd. Xinchang Pharmaceutical Factory on June 30, 2017 in Xinchang. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 30, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Xinchang (China)